HEADER HYDROLASE 12-OCT-10 2XTV TITLE STRUCTURE OF E.COLI RHOMBOID PROTEASE GLPG, ACTIVE SITE MUTANT, S201T, TITLE 2 ORTHORHOMBIC CRYSTAL FORM COMPND MOL_ID: 1; COMPND 2 MOLECULE: RHOMBOID PROTEASE GLPG; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: CORE TM DOMAIN, RESIDUES 93-272; COMPND 5 SYNONYM: INTRAMEMBRANE SERINE PROTEASE, GLPG; COMPND 6 EC: 3.4.21.105; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI; SOURCE 3 ORGANISM_TAXID: 469008; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 6 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_VARIANT: C41; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET KEYWDS HYDROLASE, MEMBRANE PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR K.R.VINOTHKUMAR REVDAT 4 20-DEC-23 2XTV 1 REMARK REVDAT 3 27-FEB-19 2XTV 1 JRNL REMARK REVDAT 2 06-APR-11 2XTV 1 JRNL REMARK REVDAT 1 02-FEB-11 2XTV 0 JRNL AUTH K.R.VINOTHKUMAR JRNL TITL STRUCTURE OF RHOMBOID PROTEASE IN A LIPID ENVIRONMENT. JRNL REF J. MOL. BIOL. V. 407 232 2011 JRNL REFN ESSN 1089-8638 JRNL PMID 21256137 JRNL DOI 10.1016/J.JMB.2011.01.029 REMARK 2 REMARK 2 RESOLUTION. 1.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.01 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 95.2 REMARK 3 NUMBER OF REFLECTIONS : 22432 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.188 REMARK 3 R VALUE (WORKING SET) : 0.186 REMARK 3 FREE R VALUE : 0.215 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1148 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 28.0127 - 3.3983 0.95 2841 138 0.2125 0.2136 REMARK 3 2 3.3983 - 2.6980 0.97 2740 145 0.1780 0.2085 REMARK 3 3 2.6980 - 2.3572 0.98 2718 158 0.1580 0.2233 REMARK 3 4 2.3572 - 2.1417 0.98 2720 152 0.1590 0.1893 REMARK 3 5 2.1417 - 1.9883 0.96 2683 133 0.1635 0.2068 REMARK 3 6 1.9883 - 1.8711 0.97 2655 152 0.1787 0.2376 REMARK 3 7 1.8711 - 1.7774 0.96 2634 142 0.1998 0.2311 REMARK 3 8 1.7774 - 1.7000 0.84 2293 128 0.2284 0.2609 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : 0.41 REMARK 3 B_SOL : 66.14 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.190 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 18.380 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 20.30 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 24.10 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 2.39310 REMARK 3 B22 (A**2) : -2.53540 REMARK 3 B33 (A**2) : 0.14230 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.006 1744 REMARK 3 ANGLE : 1.041 2299 REMARK 3 CHIRALITY : 0.072 226 REMARK 3 PLANARITY : 0.004 253 REMARK 3 DIHEDRAL : 17.144 698 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: RESIDUES 246 AND 247 ARE DISORDERED. REMARK 3 HENCE THERE IS A GAP BETWEEN 245 AND 248.THERE IS A DENSITY REMARK 3 ABOVE THE ACTIVE SITE WHICH HAS NOT BEEN MODELLED, AS NONE OF REMARK 3 COMPONENTS OF CRYSTALLISATION CAN EXPLAIN THE DENSITY. REMARK 4 REMARK 4 2XTV COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 12-OCT-10. REMARK 100 THE DEPOSITION ID IS D_1290045749. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 29-APR-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I03 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9763 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22469 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.700 REMARK 200 RESOLUTION RANGE LOW (A) : 45.540 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.8 REMARK 200 DATA REDUNDANCY : 3.300 REMARK 200 R MERGE (I) : 0.05000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.79 REMARK 200 COMPLETENESS FOR SHELL (%) : 86.9 REMARK 200 DATA REDUNDANCY IN SHELL : 3.10 REMARK 200 R MERGE FOR SHELL (I) : 0.31000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 2XOV REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.94 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.41 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.5M NACL, 0.1M BIS-TRIS, PH7, 2% REMARK 280 DMPC/CHAPSO, (ADDED ONLY TO THE PROTEIN), 298K, PH 7.0, VAPOR REMARK 280 DIFFUSION, HANGING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 19.31500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 45.54500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 29.43500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 45.54500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 19.31500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 29.43500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 ENGINEERED RESIDUE IN CHAIN A, SER 201 TO THR REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 246 REMARK 465 MET A 247 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 167 CG CD CE NZ REMARK 470 LYS A 191 CG CD CE NZ REMARK 470 MET A 249 CG SD CE REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 193 23.99 -142.58 REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 IN THE PRESENT MODEL LIPIDS (MC3) MOLECULES 504, 505, 508, 511, 513 REMARK 600 AND 514 COULD ALSO REPRESENT DETERGENT NONYL GLUCOSIDE USED FOR REMARK 600 PURIFICATION OF PROTEIN. REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 MC3 A 501 REMARK 610 MC3 A 503 REMARK 610 MC3 A 504 REMARK 610 MC3 A 505 REMARK 610 MC3 A 506 REMARK 610 MC3 A 507 REMARK 610 MC3 A 508 REMARK 610 MC3 A 509 REMARK 610 MC3 A 510 REMARK 610 MC3 A 511 REMARK 610 MC3 A 512 REMARK 610 MC3 A 513 REMARK 610 MC3 A 514 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MC3 A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MC3 A 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MC3 A 503 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MC3 A 504 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MC3 A 505 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MC3 A 506 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MC3 A 507 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MC3 A 508 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MC3 A 509 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MC3 A 510 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MC3 A 511 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MC3 A 512 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MC3 A 513 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MC3 A 514 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2IC8 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF GLPG REMARK 900 RELATED ID: 2XOV RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF E.COLI RHOMBOID PROTEASE GLPG, NATIVE ENZYME REMARK 900 RELATED ID: 2XTU RELATED DB: PDB REMARK 900 STRUCTURE OF E.COLI RHOMBOID PROTEASE GLPG ACTIVE SITE MUTANT, REMARK 900 S201T IN TRIGONAL CRYSTAL FORM REMARK 900 RELATED ID: 2XOW RELATED DB: PDB REMARK 900 STRUCTURE OF GLPG IN COMPLEX WITH A MECHANISM-BASED ISOCOUMARIN REMARK 900 INHIBITOR REMARK 900 RELATED ID: 2IRV RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF GLPG, A RHOMBOID INTRAMEMBRANE SERINEPROTEASE DBREF 2XTV A 93 272 UNP P09391 GLPG_ECOLI 93 272 SEQADV 2XTV THR A 201 UNP P09391 SER 201 ENGINEERED MUTATION SEQRES 1 A 180 ALA GLY PRO VAL THR TRP VAL MET MET ILE ALA CYS VAL SEQRES 2 A 180 VAL VAL PHE ILE ALA MET GLN ILE LEU GLY ASP GLN GLU SEQRES 3 A 180 VAL MET LEU TRP LEU ALA TRP PRO PHE ASP PRO THR LEU SEQRES 4 A 180 LYS PHE GLU PHE TRP ARG TYR PHE THR HIS ALA LEU MET SEQRES 5 A 180 HIS PHE SER LEU MET HIS ILE LEU PHE ASN LEU LEU TRP SEQRES 6 A 180 TRP TRP TYR LEU GLY GLY ALA VAL GLU LYS ARG LEU GLY SEQRES 7 A 180 SER GLY LYS LEU ILE VAL ILE THR LEU ILE SER ALA LEU SEQRES 8 A 180 LEU SER GLY TYR VAL GLN GLN LYS PHE SER GLY PRO TRP SEQRES 9 A 180 PHE GLY GLY LEU THR GLY VAL VAL TYR ALA LEU MET GLY SEQRES 10 A 180 TYR VAL TRP LEU ARG GLY GLU ARG ASP PRO GLN SER GLY SEQRES 11 A 180 ILE TYR LEU GLN ARG GLY LEU ILE ILE PHE ALA LEU ILE SEQRES 12 A 180 TRP ILE VAL ALA GLY TRP PHE ASP LEU PHE GLY MET SER SEQRES 13 A 180 MET ALA ASN GLY ALA HIS ILE ALA GLY LEU ALA VAL GLY SEQRES 14 A 180 LEU ALA MET ALA PHE VAL ASP SER LEU ASN ALA HET MC3 A 501 34 HET MC3 A 502 46 HET MC3 A 503 40 HET MC3 A 504 18 HET MC3 A 505 27 HET MC3 A 506 16 HET MC3 A 507 17 HET MC3 A 508 16 HET MC3 A 509 20 HET MC3 A 510 9 HET MC3 A 511 14 HET MC3 A 512 16 HET MC3 A 513 8 HET MC3 A 514 15 HETNAM MC3 1,2-DIMYRISTOYL-RAC-GLYCERO-3-PHOSPHOCHOLINE FORMUL 2 MC3 14(C36 H72 N O8 P) FORMUL 16 HOH *79(H2 O) HELIX 1 1 GLY A 94 GLY A 115 1 22 HELIX 2 2 GLY A 115 ALA A 124 1 10 HELIX 3 3 ASP A 128 LYS A 132 5 5 HELIX 4 4 TRP A 136 HIS A 141 1 6 HELIX 5 5 ALA A 142 MET A 144 5 3 HELIX 6 6 SER A 147 GLY A 170 1 24 HELIX 7 7 GLY A 170 GLY A 194 1 25 HELIX 8 8 LEU A 200 ASP A 218 1 19 HELIX 9 9 PRO A 219 GLY A 222 5 4 HELIX 10 10 GLN A 226 PHE A 242 1 17 HELIX 11 11 ALA A 250 ALA A 272 1 23 SITE 1 AC1 11 THR A 130 PHE A 133 GLU A 134 PHE A 135 SITE 2 AC1 11 TRP A 136 ARG A 217 ALA A 263 PHE A 266 SITE 3 AC1 11 MC3 A 503 MC3 A 505 HOH A2076 SITE 1 AC2 10 TRP A 122 PHE A 153 LEU A 156 TRP A 157 SITE 2 AC2 10 TRP A 159 TYR A 160 GLN A 226 PHE A 232 SITE 3 AC2 10 PHE A 245 HOH A2077 SITE 1 AC3 11 TRP A 136 PHE A 153 LEU A 155 LEU A 156 SITE 2 AC3 11 TRP A 159 PHE A 266 LEU A 270 MC3 A 501 SITE 3 AC3 11 MC3 A 509 MC3 A 511 HOH A2079 SITE 1 AC4 4 LEU A 184 ALA A 256 ALA A 263 MC3 A 512 SITE 1 AC5 8 LYS A 132 TYR A 138 TRP A 212 GLU A 216 SITE 2 AC5 8 MC3 A 501 MC3 A 506 MC3 A 507 MC3 A 508 SITE 1 AC6 6 VAL A 106 ILE A 109 LEU A 234 MC3 A 505 SITE 2 AC6 6 MC3 A 508 MC3 A 512 SITE 1 AC7 5 TRP A 125 LEU A 183 GLN A 190 MC3 A 505 SITE 2 AC7 5 MC3 A 508 SITE 1 AC8 4 TYR A 187 MC3 A 505 MC3 A 506 MC3 A 507 SITE 1 AC9 5 PHE A 139 ILE A 175 LEU A 179 MC3 A 503 SITE 2 AC9 5 MC3 A 510 SITE 1 BC1 1 MC3 A 509 SITE 1 BC2 3 GLN A 112 MC3 A 503 MC3 A 512 SITE 1 BC3 4 TYR A 187 MC3 A 504 MC3 A 506 MC3 A 511 SITE 1 BC4 3 PHE A 242 VAL A 267 ASN A 271 SITE 1 BC5 3 ILE A 102 PHE A 242 ASP A 243 CRYST1 38.630 58.870 91.090 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.025887 0.000000 0.000000 0.00000 SCALE2 0.000000 0.016987 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010978 0.00000